DOMS Industries (DOMS) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
9 Jul, 2026Executive summary
Achieved consolidated revenue growth of 24.4% year-over-year for FY25, driven by steady sales momentum, new product launches, Uniclan integration, and strategic acquisitions including SKIDO.
Board recommended a dividend of INR 3.15 per share, subject to approval.
Strengthened global presence through FILA partnership, enhancing export capabilities and product innovation.
Continued investment in manufacturing infrastructure, R&D, and capacity expansion to support operational efficiency and product differentiation.
Hygiene segment reported separately for the first time, reflecting impact of Uniclan and SKIDO acquisitions.
Financial highlights
Q4 FY25 consolidated revenue grew 26% year-over-year to INR 508.7 crores; FY25 revenue reached INR 1,912.6 crores, up from INR 1,537 crores in FY24.
Q4 FY25 EBITDA rose 16.2% to INR 88.3 crores; FY25 EBITDA grew 27.8% to INR 348.4 crores, margin expanded to 18.2%.
Q4 FY25 PAT up 9.3% to INR 51.3 crores; FY25 PAT up 33.7% to INR 213.5 crores; PAT margin for FY25 at 11.2%.
Gross profit margin for FY25 at 43.5%, up from 41.9% in FY24.
Operating cash flow for FY25 at INR 183.3 crores; significant investments in capex and acquisitions.
Outlook and guidance
FY26 revenue growth guidance of 18%-20% at consolidated level, including Uniclan.
EBITDA margin expected in the 16.5%-17.5% range; PAT margin around 10%.
CapEx planned at INR 225-250 crores annually for the next two years, focused on plant expansion and capacity additions.
Ongoing capacity expansion at Umbergaon, Gujarat, with first building to be operational by Q4FY26.
Unutilized IPO proceeds remain invested in fixed deposits and monitoring accounts, supporting future growth.
Latest events from DOMS Industries
- Q3 FY26 saw 18.2% revenue growth, 17.5% EBITDA margin, and robust expansion initiatives.DOMS
Q3 25/268 Jul 2026 - Q2 FY26 saw strong revenue and profit growth, capacity expansion, and product diversification.DOMS
Q2 25/2619 Jun 2026 - Q3 FY25 revenue and profit surged, supported by acquisitions, capacity expansion, and IPO funds.DOMS
Q3 24/2519 Jun 2026 - FY26 revenue up 21.6% YoY, EBITDA margin 17.3%, PAT up 12.2%, strong domestic demand.DOMS
Q4 25/2619 May 2026 - Q1 FY25 saw strong revenue and profit growth, margin expansion, and strategic diversification.DOMS
Q1 24/252 Feb 2026 - Q2 FY25 revenue and profit rose sharply, aided by Uniclan acquisition and margin expansion.DOMS
Q2 24/2515 Jan 2026 - Q1 FY26 revenue rose 26.4% with strong margins, capacity expansion, and new product launches.DOMS
Q1 25/2623 Nov 2025